nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—KCNK1—brainstem—multiple sclerosis	0.0108	0.0626	CbGeAlD
Quinidine barbiturate—KCNK1—Potassium Channels—KCNA3—multiple sclerosis	0.00923	0.0995	CbGpPWpGaD
Quinidine barbiturate—GRIA2—brainstem—multiple sclerosis	0.00882	0.0509	CbGeAlD
Quinidine barbiturate—KCNK1—medulla oblongata—multiple sclerosis	0.00756	0.0436	CbGeAlD
Quinidine barbiturate—KCNK1—midbrain—multiple sclerosis	0.00691	0.0399	CbGeAlD
Quinidine barbiturate—KCNK1—spinal cord—multiple sclerosis	0.00674	0.0389	CbGeAlD
Quinidine barbiturate—GABRA2—brainstem—multiple sclerosis	0.00573	0.0331	CbGeAlD
Quinidine barbiturate—KCNK1—nervous system—multiple sclerosis	0.00568	0.0328	CbGeAlD
Quinidine barbiturate—GRIA2—midbrain—multiple sclerosis	0.00562	0.0325	CbGeAlD
Quinidine barbiturate—GABRA1—brainstem—multiple sclerosis	0.00554	0.032	CbGeAlD
Quinidine barbiturate—GRIA2—spinal cord—multiple sclerosis	0.00549	0.0317	CbGeAlD
Quinidine barbiturate—KCNK1—central nervous system—multiple sclerosis	0.00547	0.0316	CbGeAlD
Quinidine barbiturate—KCNH2—Voltage gated Potassium channels—KCNA3—multiple sclerosis	0.00543	0.0585	CbGpPWpGaD
Quinidine barbiturate—KCNK1—cerebellum—multiple sclerosis	0.00534	0.0309	CbGeAlD
Quinidine barbiturate—GRIA2—nervous system—multiple sclerosis	0.00462	0.0267	CbGeAlD
Quinidine barbiturate—GRIA2—central nervous system—multiple sclerosis	0.00445	0.0257	CbGeAlD
Quinidine barbiturate—GRIA2—cerebellum—multiple sclerosis	0.00435	0.0251	CbGeAlD
Quinidine barbiturate—KCNK1—brain—multiple sclerosis	0.00434	0.0251	CbGeAlD
Quinidine barbiturate—KCNK1—Neuronal System—KCNA3—multiple sclerosis	0.00403	0.0435	CbGpPWpGaD
Quinidine barbiturate—GABRA1—medulla oblongata—multiple sclerosis	0.00386	0.0223	CbGeAlD
Quinidine barbiturate—GRIA2—brain—multiple sclerosis	0.00353	0.0204	CbGeAlD
Quinidine barbiturate—GABRA1—midbrain—multiple sclerosis	0.00353	0.0204	CbGeAlD
Quinidine barbiturate—GABRA1—spinal cord—multiple sclerosis	0.00344	0.0199	CbGeAlD
Quinidine barbiturate—SCN5A—nervous system—multiple sclerosis	0.00339	0.0196	CbGeAlD
Quinidine barbiturate—SCN5A—L1CAM interactions—CD24—multiple sclerosis	0.00331	0.0356	CbGpPWpGaD
Quinidine barbiturate—SCN5A—central nervous system—multiple sclerosis	0.00327	0.0189	CbGeAlD
Quinidine barbiturate—GABRA2—nervous system—multiple sclerosis	0.003	0.0173	CbGeAlD
Quinidine barbiturate—GABRA1—nervous system—multiple sclerosis	0.0029	0.0168	CbGeAlD
Quinidine barbiturate—GABRA2—central nervous system—multiple sclerosis	0.00289	0.0167	CbGeAlD
Quinidine barbiturate—CHRM2—nervous system—multiple sclerosis	0.00289	0.0167	CbGeAlD
Quinidine barbiturate—GABRA2—cerebellum—multiple sclerosis	0.00283	0.0163	CbGeAlD
Quinidine barbiturate—GABRA1—central nervous system—multiple sclerosis	0.00279	0.0161	CbGeAlD
Quinidine barbiturate—KCNH2—Potassium Channels—KCNA3—multiple sclerosis	0.00279	0.03	CbGpPWpGaD
Quinidine barbiturate—CHRM2—central nervous system—multiple sclerosis	0.00278	0.0161	CbGeAlD
Quinidine barbiturate—KCNH2—medulla oblongata—multiple sclerosis	0.00278	0.016	CbGeAlD
Quinidine barbiturate—GABRA1—cerebellum—multiple sclerosis	0.00273	0.0158	CbGeAlD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00264	0.0284	CbGpPWpGaD
Quinidine barbiturate—SCN5A—brain—multiple sclerosis	0.00259	0.015	CbGeAlD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00256	0.0275	CbGpPWpGaD
Quinidine barbiturate—KCNH2—midbrain—multiple sclerosis	0.00254	0.0146	CbGeAlD
Quinidine barbiturate—KCNH2—spinal cord—multiple sclerosis	0.00248	0.0143	CbGeAlD
Quinidine barbiturate—CYP2D6—brainstem—multiple sclerosis	0.00243	0.014	CbGeAlD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—KCNA3—multiple sclerosis	0.00234	0.0252	CbGpPWpGaD
Quinidine barbiturate—GABRA2—brain—multiple sclerosis	0.0023	0.0133	CbGeAlD
Quinidine barbiturate—GABRA1—brain—multiple sclerosis	0.00222	0.0128	CbGeAlD
Quinidine barbiturate—CHRM2—brain—multiple sclerosis	0.00221	0.0127	CbGeAlD
Quinidine barbiturate—KCNH2—nervous system—multiple sclerosis	0.00209	0.012	CbGeAlD
Quinidine barbiturate—KCNH2—central nervous system—multiple sclerosis	0.00201	0.0116	CbGeAlD
Quinidine barbiturate—KCNH2—cerebellum—multiple sclerosis	0.00196	0.0113	CbGeAlD
Quinidine barbiturate—GRIA2—N-cadherin signaling events—CNR1—multiple sclerosis	0.00188	0.0203	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—LINGO1—multiple sclerosis	0.00187	0.0201	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00174	0.0187	CbGpPWpGaD
Quinidine barbiturate—KCNH2—brain—multiple sclerosis	0.00159	0.0092	CbGeAlD
Quinidine barbiturate—GRIA2—Neuronal System—KCNA3—multiple sclerosis	0.00138	0.0148	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00136	0.0147	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—nervous system—multiple sclerosis	0.00127	0.00734	CbGeAlD
Quinidine barbiturate—SCN5A—Axon guidance—CD24—multiple sclerosis	0.00125	0.0135	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—central nervous system—multiple sclerosis	0.00122	0.00707	CbGeAlD
Quinidine barbiturate—KCNH2—Neuronal System—KCNA3—multiple sclerosis	0.00122	0.0131	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—cerebellum—multiple sclerosis	0.0012	0.00691	CbGeAlD
Quinidine barbiturate—KCNK1—Neuronal System—BCHE—multiple sclerosis	0.00113	0.0122	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00109	0.0118	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00106	0.0114	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—brain—multiple sclerosis	0.000972	0.00561	CbGeAlD
Quinidine barbiturate—GABRA2—Neuronal System—KCNA3—multiple sclerosis	0.00097	0.0105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—S1PR1—multiple sclerosis	0.000961	0.0104	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CD24—multiple sclerosis	0.000891	0.00961	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000861	0.00928	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000861	0.00928	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00085	0.00916	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00085	0.00916	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.00083	0.00894	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—KCNA3—multiple sclerosis	0.000827	0.00891	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000804	0.00867	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000721	0.00777	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000698	0.00752	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000698	0.00752	CbGpPWpGaD
Quinidine barbiturate—Syncope—Methylprednisolone—multiple sclerosis	0.00069	0.000939	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000687	0.000936	CcSEcCtD
Quinidine barbiturate—Oedema—Prednisolone—multiple sclerosis	0.000684	0.000932	CcSEcCtD
Quinidine barbiturate—Neutropenia—Methotrexate—multiple sclerosis	0.000683	0.00093	CcSEcCtD
Quinidine barbiturate—Dizziness—Azathioprine—multiple sclerosis	0.000682	0.000929	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000682	0.000929	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000677	0.000923	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000676	0.000921	CcSEcCtD
Quinidine barbiturate—Shock—Prednisolone—multiple sclerosis	0.000673	0.000917	CcSEcCtD
Quinidine barbiturate—Convulsion—Triamcinolone—multiple sclerosis	0.000668	0.00091	CcSEcCtD
Quinidine barbiturate—Tachycardia—Prednisolone—multiple sclerosis	0.000667	0.000909	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000667	0.000908	CcSEcCtD
Quinidine barbiturate—Convulsion—Methylprednisolone—multiple sclerosis	0.000666	0.000908	CcSEcCtD
Quinidine barbiturate—Urticaria—Mitoxantrone—multiple sclerosis	0.000662	0.000902	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000661	0.000901	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000659	0.000898	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000659	0.000898	CcSEcCtD
Quinidine barbiturate—Myalgia—Triamcinolone—multiple sclerosis	0.000656	0.000894	CcSEcCtD
Quinidine barbiturate—Vomiting—Azathioprine—multiple sclerosis	0.000656	0.000893	CcSEcCtD
Quinidine barbiturate—Myalgia—Methylprednisolone—multiple sclerosis	0.000655	0.000892	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methylprednisolone—multiple sclerosis	0.000655	0.000892	CcSEcCtD
Quinidine barbiturate—Eye disorder—Prednisone—multiple sclerosis	0.000654	0.000891	CcSEcCtD
Quinidine barbiturate—Anxiety—Methylprednisolone—multiple sclerosis	0.000652	0.000889	CcSEcCtD
Quinidine barbiturate—Drowsiness—Methotrexate—multiple sclerosis	0.000651	0.000887	CcSEcCtD
Quinidine barbiturate—Rash—Azathioprine—multiple sclerosis	0.00065	0.000886	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00065	0.000886	CcSEcCtD
Quinidine barbiturate—Dermatitis—Azathioprine—multiple sclerosis	0.00065	0.000885	CcSEcCtD
Quinidine barbiturate—Flushing—Prednisone—multiple sclerosis	0.000649	0.000884	CcSEcCtD
Quinidine barbiturate—Headache—Azathioprine—multiple sclerosis	0.000646	0.00088	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000646	0.00088	CcSEcCtD
Quinidine barbiturate—Renal failure—Methotrexate—multiple sclerosis	0.00064	0.000872	CcSEcCtD
Quinidine barbiturate—Angioedema—Betamethasone—multiple sclerosis	0.000639	0.00087	CcSEcCtD
Quinidine barbiturate—Angioedema—Dexamethasone—multiple sclerosis	0.000639	0.00087	CcSEcCtD
Quinidine barbiturate—GRIA2—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000638	0.00688	CbGpPWpGaD
Quinidine barbiturate—Confusional state—Methylprednisolone—multiple sclerosis	0.000633	0.000862	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Prednisone—multiple sclerosis	0.000632	0.000861	CcSEcCtD
Quinidine barbiturate—Oedema—Triamcinolone—multiple sclerosis	0.000629	0.000857	CcSEcCtD
Quinidine barbiturate—Vertigo—Betamethasone—multiple sclerosis	0.000628	0.000856	CcSEcCtD
Quinidine barbiturate—Vertigo—Dexamethasone—multiple sclerosis	0.000628	0.000856	CcSEcCtD
Quinidine barbiturate—Syncope—Betamethasone—multiple sclerosis	0.000627	0.000854	CcSEcCtD
Quinidine barbiturate—Syncope—Dexamethasone—multiple sclerosis	0.000627	0.000854	CcSEcCtD
Quinidine barbiturate—Sweating—Methotrexate—multiple sclerosis	0.000624	0.00085	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CNR1—multiple sclerosis	0.000621	0.00669	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—multiple sclerosis	0.000619	0.00667	CbGpPWpGaD
Quinidine barbiturate—Shock—Triamcinolone—multiple sclerosis	0.000619	0.000843	CcSEcCtD
Quinidine barbiturate—Shock—Methylprednisolone—multiple sclerosis	0.000617	0.000841	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000615	0.000838	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000615	0.000837	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Betamethasone—multiple sclerosis	0.000615	0.000837	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000614	0.000837	CcSEcCtD
Quinidine barbiturate—Tachycardia—Triamcinolone—multiple sclerosis	0.000614	0.000836	CcSEcCtD
Quinidine barbiturate—Mental disorder—Prednisone—multiple sclerosis	0.000613	0.000835	CcSEcCtD
Quinidine barbiturate—Nausea—Azathioprine—multiple sclerosis	0.000612	0.000834	CcSEcCtD
Quinidine barbiturate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000612	0.000834	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methylprednisolone—multiple sclerosis	0.00061	0.00083	CcSEcCtD
Quinidine barbiturate—Erythema—Prednisone—multiple sclerosis	0.000609	0.00083	CcSEcCtD
Quinidine barbiturate—Malnutrition—Prednisone—multiple sclerosis	0.000609	0.00083	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000608	0.000828	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Methotrexate—multiple sclerosis	0.000608	0.000828	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000607	0.000826	CcSEcCtD
Quinidine barbiturate—Convulsion—Dexamethasone—multiple sclerosis	0.000606	0.000825	CcSEcCtD
Quinidine barbiturate—Convulsion—Betamethasone—multiple sclerosis	0.000606	0.000825	CcSEcCtD
Quinidine barbiturate—Asthenia—Mitoxantrone—multiple sclerosis	0.000598	0.000815	CcSEcCtD
Quinidine barbiturate—Myalgia—Dexamethasone—multiple sclerosis	0.000595	0.000811	CcSEcCtD
Quinidine barbiturate—Myalgia—Betamethasone—multiple sclerosis	0.000595	0.000811	CcSEcCtD
Quinidine barbiturate—Anxiety—Dexamethasone—multiple sclerosis	0.000593	0.000808	CcSEcCtD
Quinidine barbiturate—Anxiety—Betamethasone—multiple sclerosis	0.000593	0.000808	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Methotrexate—multiple sclerosis	0.000588	0.0008	CcSEcCtD
Quinidine barbiturate—Hypotension—Methylprednisolone—multiple sclerosis	0.000586	0.000799	CcSEcCtD
Quinidine barbiturate—Pain—Prednisolone—multiple sclerosis	0.000585	0.000797	CcSEcCtD
Quinidine barbiturate—Hepatitis—Methotrexate—multiple sclerosis	0.000585	0.000796	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Methotrexate—multiple sclerosis	0.000585	0.000796	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000577	0.000786	CcSEcCtD
Quinidine barbiturate—Vision blurred—Prednisone—multiple sclerosis	0.000574	0.000782	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Methotrexate—multiple sclerosis	0.000573	0.000781	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000573	0.000781	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000572	0.000779	CcSEcCtD
Quinidine barbiturate—Oedema—Betamethasone—multiple sclerosis	0.000571	0.000777	CcSEcCtD
Quinidine barbiturate—Oedema—Dexamethasone—multiple sclerosis	0.000571	0.000777	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00057	0.000777	CcSEcCtD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000565	0.00609	CbGpPWpGaD
Quinidine barbiturate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000564	0.000768	CcSEcCtD
Quinidine barbiturate—Visual impairment—Methotrexate—multiple sclerosis	0.000563	0.000767	CcSEcCtD
Quinidine barbiturate—Shock—Betamethasone—multiple sclerosis	0.000561	0.000765	CcSEcCtD
Quinidine barbiturate—Shock—Dexamethasone—multiple sclerosis	0.000561	0.000765	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Triamcinolone—multiple sclerosis	0.000561	0.000764	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00056	0.000762	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Betamethasone—multiple sclerosis	0.00056	0.000762	CcSEcCtD
Quinidine barbiturate—Agitation—Prednisone—multiple sclerosis	0.00056	0.000762	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000559	0.000761	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000559	0.000761	CcSEcCtD
Quinidine barbiturate—Tachycardia—Betamethasone—multiple sclerosis	0.000557	0.000759	CcSEcCtD
Quinidine barbiturate—Tachycardia—Dexamethasone—multiple sclerosis	0.000557	0.000759	CcSEcCtD
Quinidine barbiturate—Angioedema—Prednisone—multiple sclerosis	0.000556	0.000758	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Methotrexate—multiple sclerosis	0.000553	0.000753	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000552	0.000752	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000552	0.000752	CcSEcCtD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.000551	0.00594	CbGpPWpGaD
Quinidine barbiturate—Vertigo—Prednisone—multiple sclerosis	0.000547	0.000745	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000547	0.00589	CbGpPWpGaD
Quinidine barbiturate—Eye disorder—Methotrexate—multiple sclerosis	0.000546	0.000744	CcSEcCtD
Quinidine barbiturate—Syncope—Prednisone—multiple sclerosis	0.000546	0.000744	CcSEcCtD
Quinidine barbiturate—Tinnitus—Methotrexate—multiple sclerosis	0.000545	0.000743	CcSEcCtD
Quinidine barbiturate—Anorexia—Dexamethasone—multiple sclerosis	0.000544	0.000741	CcSEcCtD
Quinidine barbiturate—Anorexia—Betamethasone—multiple sclerosis	0.000544	0.000741	CcSEcCtD
Quinidine barbiturate—Urticaria—Prednisolone—multiple sclerosis	0.000543	0.00074	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Methotrexate—multiple sclerosis	0.000543	0.000739	CcSEcCtD
Quinidine barbiturate—Pain—Triamcinolone—multiple sclerosis	0.000538	0.000733	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Prednisone—multiple sclerosis	0.000535	0.000729	CcSEcCtD
Quinidine barbiturate—Hypotension—Betamethasone—multiple sclerosis	0.000533	0.000726	CcSEcCtD
Quinidine barbiturate—Hypotension—Dexamethasone—multiple sclerosis	0.000533	0.000726	CcSEcCtD
Quinidine barbiturate—Vomiting—Mitoxantrone—multiple sclerosis	0.00053	0.000722	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Methotrexate—multiple sclerosis	0.000528	0.000719	CcSEcCtD
Quinidine barbiturate—Convulsion—Prednisone—multiple sclerosis	0.000528	0.000719	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000527	0.000718	CcSEcCtD
Quinidine barbiturate—Rash—Mitoxantrone—multiple sclerosis	0.000526	0.000716	CcSEcCtD
Quinidine barbiturate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000525	0.000715	CcSEcCtD
Quinidine barbiturate—Chills—Methotrexate—multiple sclerosis	0.000525	0.000715	CcSEcCtD
Quinidine barbiturate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.000523	0.00564	CbGpPWpGaD
Quinidine barbiturate—Headache—Mitoxantrone—multiple sclerosis	0.000522	0.000711	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00052	0.000708	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00052	0.000708	CcSEcCtD
Quinidine barbiturate—Arthralgia—Prednisone—multiple sclerosis	0.000518	0.000706	CcSEcCtD
Quinidine barbiturate—Myalgia—Prednisone—multiple sclerosis	0.000518	0.000706	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000518	0.000706	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000517	0.000704	CcSEcCtD
Quinidine barbiturate—Anxiety—Prednisone—multiple sclerosis	0.000517	0.000704	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000515	0.000701	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000513	0.000699	CcSEcCtD
Quinidine barbiturate—Mental disorder—Methotrexate—multiple sclerosis	0.000512	0.000698	CcSEcCtD
Quinidine barbiturate—Malnutrition—Methotrexate—multiple sclerosis	0.000509	0.000693	CcSEcCtD
Quinidine barbiturate—Erythema—Methotrexate—multiple sclerosis	0.000509	0.000693	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000504	0.00543	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000504	0.000686	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—BDNF—multiple sclerosis	0.000502	0.00541	CbGpPWpGaD
Quinidine barbiturate—Urticaria—Triamcinolone—multiple sclerosis	0.0005	0.000681	CcSEcCtD
Quinidine barbiturate—Urticaria—Methylprednisolone—multiple sclerosis	0.000499	0.000679	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000497	0.000677	CcSEcCtD
Quinidine barbiturate—Oedema—Prednisone—multiple sclerosis	0.000497	0.000677	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000496	0.000676	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000496	0.000676	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Betamethasone—multiple sclerosis	0.000496	0.000676	CcSEcCtD
Quinidine barbiturate—Nausea—Mitoxantrone—multiple sclerosis	0.000495	0.000675	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000493	0.000671	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000493	0.000671	CcSEcCtD
Quinidine barbiturate—Shock—Prednisone—multiple sclerosis	0.000489	0.000666	CcSEcCtD
Quinidine barbiturate—Pain—Dexamethasone—multiple sclerosis	0.000488	0.000665	CcSEcCtD
Quinidine barbiturate—Pain—Betamethasone—multiple sclerosis	0.000488	0.000665	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Prednisone—multiple sclerosis	0.000487	0.000664	CcSEcCtD
Quinidine barbiturate—Tachycardia—Prednisone—multiple sclerosis	0.000485	0.000661	CcSEcCtD
Quinidine barbiturate—Skin disorder—Prednisone—multiple sclerosis	0.000483	0.000658	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Prednisone—multiple sclerosis	0.00048	0.000654	CcSEcCtD
Quinidine barbiturate—Vision blurred—Methotrexate—multiple sclerosis	0.00048	0.000653	CcSEcCtD
Quinidine barbiturate—Anorexia—Prednisone—multiple sclerosis	0.000474	0.000645	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00047	0.000641	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Betamethasone—multiple sclerosis	0.00047	0.000641	CcSEcCtD
Quinidine barbiturate—CHRM2—GPCRs, Other—CXCR3—multiple sclerosis	0.000469	0.00506	CbGpPWpGaD
Quinidine barbiturate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000467	0.000636	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000467	0.000636	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000463	0.000631	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000462	0.00063	CcSEcCtD
Quinidine barbiturate—Vertigo—Methotrexate—multiple sclerosis	0.000457	0.000623	CcSEcCtD
Quinidine barbiturate—Leukopenia—Methotrexate—multiple sclerosis	0.000456	0.000621	CcSEcCtD
Quinidine barbiturate—Urticaria—Betamethasone—multiple sclerosis	0.000453	0.000618	CcSEcCtD
Quinidine barbiturate—Urticaria—Dexamethasone—multiple sclerosis	0.000453	0.000618	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000453	0.000617	CcSEcCtD
Quinidine barbiturate—Dizziness—Prednisolone—multiple sclerosis	0.000452	0.000616	CcSEcCtD
Quinidine barbiturate—Asthenia—Triamcinolone—multiple sclerosis	0.000451	0.000615	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Betamethasone—multiple sclerosis	0.000451	0.000615	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000451	0.000615	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Betamethasone—multiple sclerosis	0.000451	0.000615	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000451	0.000615	CcSEcCtD
Quinidine barbiturate—Asthenia—Methylprednisolone—multiple sclerosis	0.00045	0.000613	CcSEcCtD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.00045	0.00485	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—SPP1—multiple sclerosis	0.000446	0.0048	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Triamcinolone—multiple sclerosis	0.000445	0.000606	CcSEcCtD
Quinidine barbiturate—Pruritus—Methylprednisolone—multiple sclerosis	0.000444	0.000605	CcSEcCtD
Quinidine barbiturate—Convulsion—Methotrexate—multiple sclerosis	0.000441	0.000601	CcSEcCtD
Quinidine barbiturate—Chest pain—Methotrexate—multiple sclerosis	0.000433	0.00059	CcSEcCtD
Quinidine barbiturate—Myalgia—Methotrexate—multiple sclerosis	0.000433	0.00059	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methotrexate—multiple sclerosis	0.000433	0.00059	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Prednisone—multiple sclerosis	0.000432	0.000589	CcSEcCtD
Quinidine barbiturate—Rash—Prednisolone—multiple sclerosis	0.000431	0.000587	CcSEcCtD
Quinidine barbiturate—Dermatitis—Prednisolone—multiple sclerosis	0.000431	0.000587	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00043	0.000586	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000429	0.000585	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000429	0.00463	CbGpPWpGaD
Quinidine barbiturate—Headache—Prednisolone—multiple sclerosis	0.000428	0.000584	CcSEcCtD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000428	0.00461	CbGpPWpGaD
Quinidine barbiturate—Constipation—Prednisone—multiple sclerosis	0.000425	0.000579	CcSEcCtD
Quinidine barbiturate—CHRM2—GPCRs, Other—CNR1—multiple sclerosis	0.000421	0.00454	CbGpPWpGaD
Quinidine barbiturate—Confusional state—Methotrexate—multiple sclerosis	0.000419	0.00057	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000416	0.00448	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Triamcinolone—multiple sclerosis	0.000416	0.000567	CcSEcCtD
Quinidine barbiturate—Dizziness—Methylprednisolone—multiple sclerosis	0.000415	0.000565	CcSEcCtD
Quinidine barbiturate—SCN5A—Axon guidance—PRNP—multiple sclerosis	0.000412	0.00444	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00041	0.00442	CbGpPWpGaD
Quinidine barbiturate—Feeling abnormal—Prednisone—multiple sclerosis	0.00041	0.000558	CcSEcCtD
Quinidine barbiturate—Asthenia—Betamethasone—multiple sclerosis	0.000409	0.000558	CcSEcCtD
Quinidine barbiturate—Asthenia—Dexamethasone—multiple sclerosis	0.000409	0.000558	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methotrexate—multiple sclerosis	0.000407	0.000555	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000407	0.000554	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000406	0.000554	CcSEcCtD
Quinidine barbiturate—Nausea—Prednisolone—multiple sclerosis	0.000406	0.000553	CcSEcCtD
Quinidine barbiturate—Pruritus—Dexamethasone—multiple sclerosis	0.000404	0.00055	CcSEcCtD
Quinidine barbiturate—Pruritus—Betamethasone—multiple sclerosis	0.000404	0.00055	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methotrexate—multiple sclerosis	0.000403	0.00055	CcSEcCtD
Quinidine barbiturate—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000403	0.00435	CbGpPWpGaD
Quinidine barbiturate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000402	0.000547	CcSEcCtD
Quinidine barbiturate—Vomiting—Triamcinolone—multiple sclerosis	0.0004	0.000545	CcSEcCtD
Quinidine barbiturate—Vomiting—Methylprednisolone—multiple sclerosis	0.000399	0.000544	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000397	0.00428	CbGpPWpGaD
Quinidine barbiturate—Rash—Triamcinolone—multiple sclerosis	0.000397	0.00054	CcSEcCtD
Quinidine barbiturate—Dermatitis—Triamcinolone—multiple sclerosis	0.000396	0.00054	CcSEcCtD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—TGFB1—multiple sclerosis	0.000396	0.00427	CbGpPWpGaD
Quinidine barbiturate—Anorexia—Methotrexate—multiple sclerosis	0.000396	0.000539	CcSEcCtD
Quinidine barbiturate—Rash—Methylprednisolone—multiple sclerosis	0.000396	0.000539	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000395	0.000539	CcSEcCtD
Quinidine barbiturate—Urticaria—Prednisone—multiple sclerosis	0.000395	0.000538	CcSEcCtD
Quinidine barbiturate—Headache—Triamcinolone—multiple sclerosis	0.000394	0.000537	CcSEcCtD
Quinidine barbiturate—Headache—Methylprednisolone—multiple sclerosis	0.000393	0.000536	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Prednisone—multiple sclerosis	0.000393	0.000535	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Prednisone—multiple sclerosis	0.000393	0.000535	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Dexamethasone—multiple sclerosis	0.00039	0.000532	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Betamethasone—multiple sclerosis	0.00039	0.000532	CcSEcCtD
Quinidine barbiturate—Hypotension—Methotrexate—multiple sclerosis	0.000388	0.000529	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—BCHE—multiple sclerosis	0.000386	0.00416	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000382	0.00412	CbGpPWpGaD
Quinidine barbiturate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000378	0.000515	CcSEcCtD
Quinidine barbiturate—Dizziness—Betamethasone—multiple sclerosis	0.000377	0.000514	CcSEcCtD
Quinidine barbiturate—Dizziness—Dexamethasone—multiple sclerosis	0.000377	0.000514	CcSEcCtD
Quinidine barbiturate—Nausea—Triamcinolone—multiple sclerosis	0.000374	0.000509	CcSEcCtD
Quinidine barbiturate—Nausea—Methylprednisolone—multiple sclerosis	0.000373	0.000508	CcSEcCtD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000371	0.004	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000371	0.004	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Methotrexate—multiple sclerosis	0.00037	0.000504	CcSEcCtD
Quinidine barbiturate—Somnolence—Methotrexate—multiple sclerosis	0.000369	0.000503	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Prednisone—multiple sclerosis	0.000366	0.000499	CcSEcCtD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000366	0.00394	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000366	0.00394	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Dexamethasone—multiple sclerosis	0.000363	0.000494	CcSEcCtD
Quinidine barbiturate—Vomiting—Betamethasone—multiple sclerosis	0.000363	0.000494	CcSEcCtD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	0.000362	0.00391	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000361	0.00389	CbGpPWpGaD
Quinidine barbiturate—Decreased appetite—Methotrexate—multiple sclerosis	0.000361	0.000492	CcSEcCtD
Quinidine barbiturate—Rash—Betamethasone—multiple sclerosis	0.00036	0.00049	CcSEcCtD
Quinidine barbiturate—Rash—Dexamethasone—multiple sclerosis	0.00036	0.00049	CcSEcCtD
Quinidine barbiturate—Dermatitis—Betamethasone—multiple sclerosis	0.000359	0.00049	CcSEcCtD
Quinidine barbiturate—Dermatitis—Dexamethasone—multiple sclerosis	0.000359	0.00049	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000359	0.000488	CcSEcCtD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000358	0.00386	CbGpPWpGaD
Quinidine barbiturate—Headache—Betamethasone—multiple sclerosis	0.000357	0.000487	CcSEcCtD
Quinidine barbiturate—Headache—Dexamethasone—multiple sclerosis	0.000357	0.000487	CcSEcCtD
Quinidine barbiturate—Asthenia—Prednisone—multiple sclerosis	0.000357	0.000486	CcSEcCtD
Quinidine barbiturate—Pain—Methotrexate—multiple sclerosis	0.000355	0.000484	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000355	0.00383	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Prednisone—multiple sclerosis	0.000352	0.000479	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000342	0.000466	CcSEcCtD
Quinidine barbiturate—KCNH2—Neuronal System—BCHE—multiple sclerosis	0.000341	0.00368	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Prednisone—multiple sclerosis	0.00034	0.000463	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00034	0.000463	CcSEcCtD
Quinidine barbiturate—Nausea—Dexamethasone—multiple sclerosis	0.000339	0.000462	CcSEcCtD
Quinidine barbiturate—Nausea—Betamethasone—multiple sclerosis	0.000339	0.000462	CcSEcCtD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000336	0.00363	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000332	0.00357	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000332	0.00357	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—MAPK1—multiple sclerosis	0.00033	0.00356	CbGpPWpGaD
Quinidine barbiturate—Urticaria—Methotrexate—multiple sclerosis	0.00033	0.000449	CcSEcCtD
Quinidine barbiturate—Dizziness—Prednisone—multiple sclerosis	0.000329	0.000448	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Methotrexate—multiple sclerosis	0.000328	0.000447	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methotrexate—multiple sclerosis	0.000328	0.000447	CcSEcCtD
Quinidine barbiturate—SCN5A—Axon guidance—PTPRC—multiple sclerosis	0.00032	0.00345	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Prednisone—multiple sclerosis	0.000316	0.00043	CcSEcCtD
Quinidine barbiturate—Rash—Prednisone—multiple sclerosis	0.000313	0.000427	CcSEcCtD
Quinidine barbiturate—Dermatitis—Prednisone—multiple sclerosis	0.000313	0.000426	CcSEcCtD
Quinidine barbiturate—Headache—Prednisone—multiple sclerosis	0.000311	0.000424	CcSEcCtD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000308	0.00332	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000308	0.00332	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000306	0.000417	CcSEcCtD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000303	0.00326	CbGpPWpGaD
Quinidine barbiturate—Asthenia—Methotrexate—multiple sclerosis	0.000298	0.000406	CcSEcCtD
Quinidine barbiturate—Nausea—Prednisone—multiple sclerosis	0.000295	0.000402	CcSEcCtD
Quinidine barbiturate—CHRM2—GPCRs, Other—CCR5—multiple sclerosis	0.000294	0.00317	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PRNP—multiple sclerosis	0.000294	0.00317	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Methotrexate—multiple sclerosis	0.000294	0.0004	CcSEcCtD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000288	0.00311	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Methotrexate—multiple sclerosis	0.000284	0.000387	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000283	0.00305	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Methotrexate—multiple sclerosis	0.000275	0.000374	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000274	0.00295	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—S1PR1—multiple sclerosis	0.000272	0.00294	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—BCHE—multiple sclerosis	0.000272	0.00293	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00027	0.00291	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Methotrexate—multiple sclerosis	0.000264	0.00036	CcSEcCtD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000264	0.00284	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000264	0.00284	CbGpPWpGaD
Quinidine barbiturate—Rash—Methotrexate—multiple sclerosis	0.000262	0.000357	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methotrexate—multiple sclerosis	0.000262	0.000356	CcSEcCtD
Quinidine barbiturate—Headache—Methotrexate—multiple sclerosis	0.00026	0.000354	CcSEcCtD
Quinidine barbiturate—Nausea—Methotrexate—multiple sclerosis	0.000247	0.000336	CcSEcCtD
Quinidine barbiturate—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	0.000241	0.0026	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000233	0.00252	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—BCHE—multiple sclerosis	0.000232	0.0025	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	0.000229	0.00246	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000221	0.00239	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00022	0.00237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GPR65—multiple sclerosis	0.00022	0.00237	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000216	0.00233	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000215	0.00232	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CCR2—multiple sclerosis	0.000214	0.0023	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000211	0.00228	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000211	0.00228	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—STAT3—multiple sclerosis	0.000211	0.00227	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000208	0.00225	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000204	0.0022	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCR1—multiple sclerosis	0.000201	0.00216	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL13—multiple sclerosis	0.000201	0.00216	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000198	0.00214	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CNR1—multiple sclerosis	0.000197	0.00213	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000196	0.00211	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000194	0.00209	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000192	0.00207	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000191	0.00206	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000188	0.00203	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000185	0.00199	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000183	0.00197	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000181	0.00195	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.000178	0.00191	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000175	0.00188	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00017	0.00183	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000163	0.00176	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000157	0.00169	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000157	0.00169	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000156	0.00168	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000154	0.00166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000153	0.00165	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000151	0.00163	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000147	0.00159	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—TYK2—multiple sclerosis	0.000143	0.00155	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL3—multiple sclerosis	0.000143	0.00154	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000142	0.00153	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000141	0.00152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—S1PR1—multiple sclerosis	0.00014	0.00151	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000138	0.00149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—PTGER4—multiple sclerosis	0.000138	0.00148	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000138	0.00148	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCR3—multiple sclerosis	0.000133	0.00143	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RGS1—multiple sclerosis	0.000131	0.00141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCR2—multiple sclerosis	0.000129	0.00139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000128	0.00138	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000126	0.00136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GPR65—multiple sclerosis	0.000124	0.00134	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000122	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000122	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CNR1—multiple sclerosis	0.000119	0.00129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RGS1—multiple sclerosis	0.000119	0.00128	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000118	0.00127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	0.000113	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000113	0.00122	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP9—multiple sclerosis	0.000113	0.00122	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MAPK1—multiple sclerosis	0.000113	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	0.000113	0.00121	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000111	0.00119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000109	0.00118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	0.000109	0.00117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	0.000108	0.00116	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000108	0.00116	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000104	0.00112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	0.000103	0.00111	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	0.000103	0.00111	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000103	0.00111	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TYK2—multiple sclerosis	0.000102	0.0011	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MAPK1—multiple sclerosis	9.97e-05	0.00107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	9.45e-05	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	9.25e-05	0.000998	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MAPK1—multiple sclerosis	9.13e-05	0.000984	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SRM—multiple sclerosis	9e-05	0.00097	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.85e-05	0.000953	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	8.76e-05	0.000945	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	8.56e-05	0.000922	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	8.37e-05	0.000902	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—POMC—multiple sclerosis	8.34e-05	0.000899	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	8.34e-05	0.000899	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.29e-05	0.000894	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	8.26e-05	0.00089	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—multiple sclerosis	8.06e-05	0.000869	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	8.04e-05	0.000867	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	8.03e-05	0.000866	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MAPK1—multiple sclerosis	7.95e-05	0.000857	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	7.78e-05	0.000839	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	7.52e-05	0.00081	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	7.34e-05	0.000791	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	7.31e-05	0.000788	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—multiple sclerosis	7.16e-05	0.000772	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	7.07e-05	0.000762	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	7.02e-05	0.000757	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—multiple sclerosis	7.01e-05	0.000756	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.89e-05	0.000743	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	6.83e-05	0.000736	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MAPK1—multiple sclerosis	6.78e-05	0.000731	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	6.75e-05	0.000727	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	6.65e-05	0.000717	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	6.64e-05	0.000716	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	6.64e-05	0.000716	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	6.52e-05	0.000702	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	6.51e-05	0.000702	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6.49e-05	0.0007	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	6.38e-05	0.000687	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	6.34e-05	0.000683	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	6.34e-05	0.000683	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—multiple sclerosis	6.2e-05	0.000668	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	6.13e-05	0.00066	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	6.09e-05	0.000656	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	6.09e-05	0.000656	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	6.08e-05	0.000655	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.87e-05	0.000633	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GPC5—multiple sclerosis	5.8e-05	0.000625	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	5.52e-05	0.000595	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	5.23e-05	0.000564	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—multiple sclerosis	5e-05	0.000539	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—RRM1—multiple sclerosis	4.81e-05	0.000518	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	4.75e-05	0.000512	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	4.71e-05	0.000508	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	4.64e-05	0.000501	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	4.34e-05	0.000467	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	4.28e-05	0.000461	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	4.22e-05	0.000455	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	4.17e-05	0.00045	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PGR—multiple sclerosis	4.11e-05	0.000443	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	4.03e-05	0.000435	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD28—multiple sclerosis	3.99e-05	0.000431	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	3.92e-05	0.000423	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	3.68e-05	0.000397	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	3.62e-05	0.00039	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	3.34e-05	0.00036	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	3.27e-05	0.000353	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	3.26e-05	0.000351	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	2.97e-05	0.00032	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD86—multiple sclerosis	2.85e-05	0.000307	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	2.81e-05	0.000302	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.76e-05	0.000298	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	2.72e-05	0.000293	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	2.6e-05	0.00028	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	2.53e-05	0.000272	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	2.49e-05	0.000269	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	2.47e-05	0.000266	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOE—multiple sclerosis	2.3e-05	0.000248	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD80—multiple sclerosis	2.08e-05	0.000224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.98e-05	0.000213	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.93e-05	0.000208	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.89e-05	0.000204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.75e-05	0.000189	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOE—multiple sclerosis	1.66e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2—multiple sclerosis	1.46e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	1.45e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—POMC—multiple sclerosis	1.43e-05	0.000154	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	1.38e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALB—multiple sclerosis	1.3e-05	0.00014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	1.23e-05	0.000132	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—multiple sclerosis	1.14e-05	0.000123	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	1.14e-05	0.000123	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	1.12e-05	0.00012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—multiple sclerosis	8.58e-06	9.25e-05	CbGpPWpGaD
